How to identify micronuclear dysfunction?
Best insight from top research papers
Micronuclear dysfunction can be identified through various methods. One approach is the use of the micronucleus technique, which involves measuring chromosomal damage in mitogen-stimulated human lymphocytes. This technique can be performed using two different methods. The first method involves pulse-labeling lymphocytes with [3H]thymidine and identifying cells that have undergone their first mitosis through autoradiography. Micronuclei can then be scored in these cells . The second method involves blocking cytokinesis using cytochalasin B, which allows for the easy recognition and scoring of micronuclei in cytokinesis-blocked cells . Additionally, computer detection and counting techniques using digital image processing and pattern recognition have been developed, enabling automated detection and quantification of micronuclei configurations . The presence of micronuclei in a cell can indicate DNA damage and genetic instability, and the morphological and functional varieties of micronuclei can be determined by the chromosomal material localized inside these structures . Micronuclei play a role in chromosomal instability and can lead to gene loss, and damaged DNA in micronuclei can induce a defective cell cycle checkpoint arrest and DNA repair response .
Answers from top 4 papers
More filters
| Papers (4) | Insight |
|---|---|
60 Citations | Micronuclear dysfunction can be identified by compromised integrity of the micronuclear envelope, delayed or disrupted DNA replication, inhibited DNA repair, and exposure of micronuclear DNA to the cytoplasm. |
122 Citations | The paper does not provide specific information on how to identify micronuclear dysfunction. |
| The paper does not provide specific information on how to identify micronuclear dysfunction. | |
1.7K Citations | The paper does not provide information on how to identify micronuclear dysfunction. |
Related Questions
What is genotoxicity?4 answersGenotoxicity refers to the ability of certain agents, such as chemicals and radiation, to induce damage to the genetic material of cells, leading to mutations that can result in cancer or heritable changes. This damage can affect DNA and chromosomes, causing alterations at the molecular level that may impact fertility and increase cancer risk. Various genotoxicity tests, including Ames Assay, Comet Assay, and in vitro and in vivo Toxicology Tests, have been developed to assess the potential of chemicals to cause DNA damage and subsequent genetic harm. Genotoxicity testing is crucial for evaluating the safety of substances, guiding risk assessment, and determining appropriate labeling for chemical substances. New emerging methods, such as in silico, in vitro, and in vivo testing, are continuously being developed to enhance genetic toxicity evaluation.
How can a chemical is genotoxic? using Micronucleus aasay?4 answersA chemical can be assessed for genotoxicity using the Micronucleus (MN) assay, which detects genetic damage by evaluating the presence of micronuclei in cells. This assay is crucial in assessing the impact of chemicals on genetic material and is widely used in both in vivo and in vitro settings. Recent advancements have introduced automated approaches, such as imaging flow cytometry (IFC) and artificial intelligence (AI) methods, to enhance the efficiency and accuracy of scoring the MN assay. Machine learning-based tools have also been developed to predict the toxicity of compounds with high precision, reducing uncertainties and costs associated with traditional in vivo experiments. By utilizing these innovative techniques, researchers can effectively identify structural alerts in chemicals that may lead to genotoxicity, aiding in the assessment of potential risks to human health and the environment.
What are the causes and consequences of micronuclei?4 answersMicronuclei are small chromatin bodies that form in the cytoplasm due to chromosomal damage or incomplete segregation during cell division. They can be induced by various factors such as environmental pollution, mutagens, and carcinogens. Micronuclei serve as biomarkers for chromosomal aberrations, genotoxic stress, and genetic instability in both humans and animals. The consequences of micronucleus formation extend beyond being biomarkers and can have significant impacts on tumor biology. The frequent rupture of micronuclei's nuclear envelopes leads to DNA exposure in the cytoplasm, resulting in DNA rearrangement and activation of the cGAS-STING innate immune signaling pathway. Micronuclei assays are widely used to investigate genotoxic effects, genetic susceptibility, risk assessment, and disease progression, including developmental defects, cancer, and age-related diseases.
What are the different ways to diagnose post-operative cognitive dysfunction?5 answersPost-operative cognitive dysfunction (POCD) can be diagnosed using neuropsychological tests (NPTs). These tests assess various cognitive domains such as attention, memory, language, executive functioning, and perceptual-motor function. Commonly used NPTs include the Mini-Mental State Examination (MMSE), the digit span test, the trail making test, and the digit symbol substitution test. The timing of assessment is important, with neurocognitive testing typically performed shortly before surgery and at 7 days postoperatively. The diagnosis of POCD requires comparing the test results before and after surgery, and there is a need for consensus on what test results would be considered "positive" for POCD. It is important to note that POCD can be subtle and overlooked, so objective assessment with neuropsychological tests is crucial for diagnosis.
Are microparticles endothelial dysfunction a potential biomarker for cerebral small vessel disease?3 answersMicroparticles derived from endothelial dysfunction have been proposed as potential biomarkers for cerebral small vessel disease (CSVD). CSVD is a spectrum of pathological processes affecting the brain microcirculation, and it is associated with neuroinflammation and neurodegeneration. The formation of microparticles, which are small vesicles released from various cellular origins, including endothelial cells, can contribute to microthrombosis in the brain microcirculation, leading to CSVD manifestations. These microparticles have been shown to act as procoagulant factors and may serve as a plausible culprit for the vulnerable end-artery microcirculation in the brain. However, more research is needed to fully understand the role of microparticles in CSVD and their potential as biomarkers for early diagnosis and treatment.
How do you identify a cytokine storm?7 answers